Page 14 - Dyslipidaemia_newsletter8_2024_Final
P. 14
REFLECTIONS
Dyslipidaemia
Dyslipidaemia Global Newsletter #8 2024
Finally, the authors highlight the need for greater awareness of
the unique challenges faced by women with dyslipidemia during
their reproductive years and advocate for improved coordination
Dyslipidaemia
of care through a multidisciplinary cardio-obstetrics team.
Attention to the “fourth trimester”, the 12 weeks after delivery,
for ongoing CVD risk factor management is important and is
the key time to address contraception, mental health, CV risk
factors, and identify potential postpartum complications.
The authors focus on providing practical guidance for clinicians,
emphasizing the need for personalised care that considers the
individual patient’s circumstances and risk factors.
CLICK HERE
FOR RESOURCES FROM THE
NATIONAL LIPID ASSOCIATION,
INCLUDING A SLIDE SET AND VISUAL CLICK HERE
ABSTRACT. FOR THE LINK TO FULL ARTICLE
ARTICLES OF INTEREST
GUIDELINES AND POSITION STATEMENTS
1. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the management of lower
extremity peripheral artery disease: A Report of the American College of Cardiology/American Heart Association
Joint Committee on Clinical Practice Guidelines. Gornik HL, et al. J Am Coll Cardiol. 2024 Jun 18;83(24):2497-2604.
2. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An expert clinical consensus
from the national lipid association. Soffer DE, et al. J Clin Lipidol. 2024 Sep 5:S1933-2874(24)00240-X. doi: 10.1016/j.
jacl.2024.08.013. Online ahead of print.
EPIDEMIOLOGY
3. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-
2021: a systematic analysis for the Global Burden of Disease Study 2021. GBD 2021 Risk Factors Collaborators.
Lancet. 2024 May 18;403(10440):2162-2203.
4. Association between very high HDL-C levels and mortality: A systematic review and meta-analysis. Mamede I, et al.
J Clin Lipidol. 2024 Jun 12:S1933-2874(24)00203-4. doi: 10.1016/j.jacl.2024.06.002. Online ahead of print.
5. Excess apolipoprotein B and cardiovascular risk in women and men. Johannesen CDL, et al. J Am Coll Cardiol. 2024
Jun 11;83(23):2262-2273.
6. Impact of lipoprotein(a) level on low-density lipoprotein cholesterol- or apolipoprotein B-related risk of coronary
heart disease. Arnold N, et al. J Am Coll Cardiol. 2024 Jul 9;84(2):165-177.
TABLE OF CONTENTS
